Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
117 studies found for:    Hereditary Neuropathies
Show Display Options
Rank Status Study
21 Completed Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey
Condition: Leber Hereditary Optic Neuropathy (LHON)
Intervention:
22 Completed RHODOS Follow-up Single-visit Study
Condition: Leber's Hereditary Optic Neuropathy
Intervention:
23 Withdrawn Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
Condition: Leber's Hereditary Optic Neuropathy
Interventions: Drug: Idebenone;   Drug: Placebo
24 Not yet recruiting Post Authorisation Safety Study With Raxone in LHON Patients
Condition: Leber's Hereditary Optic Neuropathy (LHON)
Intervention: Drug: Idebenone
25 Recruiting Study to Assess the Efficacy and Safety of Raxone in LHON Patients
Condition: Leber's Hereditary Optic Neuropathy (LHON)
Intervention: Drug: Idebenone
26 Completed Ascorbic Acid Treatment in CMT1A Trial (AATIC)
Conditions: Charcot-Marie-Tooth Disease;   Hereditary Motor and Sensory Neuropathies
Interventions: Drug: Placebo;   Drug: ascorbic acid
27 Completed Natural History in CCFDN and IBM Syndromes
Conditions: Inclusion Body Myositis, Sporadic;   Inclusion Body Myopathy, Autosomal-recessive;   Inclusion Body Myopathy, Autosomal-dominant;   Congenital Cataracts, Facial Dysmorphism, And Neuropathy
Intervention: Other: Natural History
28 Not yet recruiting Identification of Tongue Involvement in Late-Onset Pompe Disease
Conditions: Myopathy;   Neuropathy;   Glycogen Storage Disease Type II (Late-onset Pompe Disease)
Intervention: Other: Observational study
29 Enrolling by invitation Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease
Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
30 Recruiting Study of Inherited Neurological Disorders
Conditions: Ataxia;   Motor Neuron Disease;   Muscular Disease;   Muscular Dystrophy;   Peripheral Nervous System Disease
Intervention:
31 Recruiting Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy;   Hereditary Axonal Neuropathy;   Hereditary Demyelinated Neuropathy;   Polyneuropathy, Inflammatory Demyelinating, Chronic
Intervention:
32 Unknown  Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
Conditions: Charcot-Marie-Tooth Disease;   Charcot-Marie-Tooth Disease Type 1A
Interventions: Other: TreSPE;   Other: SPE
33 Available Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Conditions: TTR-mediated Amyloidosis;   Amyloidosis, Hereditary;   Amyloid Neuropathies, Familial;   Familial Amyloid Polyneuropathies;   Amyloid Neuropathies;   Amyloidosis, Hereditary, Transthyretin-Related
Intervention: Drug: patisiran (ALN-TTR02)
34 Recruiting iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy
Conditions: Leukemia;   Lymphoma
Intervention:
35 Enrolling by invitation A Long-Term Extension Study of RP103-MITO-001 to Assess RP103 in Children With Inherited Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules
36 Completed Phenotype/Genotype Correlations in Neuromuscular Disorders
Condition: Neuromuscular Disease
Intervention:
37 Recruiting Painful Channelopathies Study
Conditions: Erythromelalgia;   Pain Insensitivity, Congenital;   Hereditary Sensory and Autonomic Neuropathies;   Chronic Pain
Intervention: Other: Observation
38 Completed Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Conditions: Arteriovenous Malformation;   Hereditary Hemorrhagic Telangiectasia;   Hematochezia;   Melena
Intervention: Drug: Thalidomide
39 Not yet recruiting Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A
Condition: CMT1A
Interventions: Drug: EllaOne;   Drug: EllaOne placebo
40 Recruiting Influence of Pronator Teres Release on Treatment of Median Nerve Compression Neuropathy
Condition: Median Nerve Compression
Interventions: Procedure: Pronator Teres Release;   Procedure: dual compression release;   Procedure: median nerve release only

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.